These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 12883660)
1. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue. Vanveldhuizen PJ; Zulfiqar M; Banerjee S; Cherian R; Saxena NK; Rabe A; Thrasher JB; Banerjee SK Oncol Rep; 2003; 10(5):1067-71. PubMed ID: 12883660 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction. Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102 [TBL] [Abstract][Full Text] [Related]
4. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells. Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440 [TBL] [Abstract][Full Text] [Related]
9. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy. Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate. Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520 [TBL] [Abstract][Full Text] [Related]
12. A novel component of the ubiquitin pathway, ubiquitin carboxyl extension protein 1 is overexpressed in prostate cancer. Ko Y; Hahn T; Lu H; Ma ZL; Chen J; Rothe M; Florin A; Fronhoffs S; Albers P; Sachinidis A; Vetter H; Kaminski A; Behrens P; Wellmann A; Wernert N Int J Mol Med; 2005 Feb; 15(2):183-96. PubMed ID: 15647830 [TBL] [Abstract][Full Text] [Related]
13. INSL3 in the benign hyperplastic and neoplastic human prostate gland. Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410 [TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone receptor expression in the human prostate. Tieva A ; Stattin P; Wikström P; Bergh A; Damber JE Prostate; 2001 Jun; 47(4):276-84. PubMed ID: 11398175 [TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Baba T; Kariya M; Higuchi T; Mandai M; Matsumura N; Kondoh E; Miyanishi M; Fukuhara K; Takakura K; Fujii S Gynecol Oncol; 2007 Jun; 105(3):703-11. PubMed ID: 17376520 [TBL] [Abstract][Full Text] [Related]
16. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium. Hess AP; Schanz A; Baston-Buest DM; Hirchenhain J; Stoff-Khalili MA; Bielfeld P; Kruessel JS J Reprod Immunol; 2009 Jan; 79(2):129-36. PubMed ID: 18996601 [TBL] [Abstract][Full Text] [Related]
17. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661 [TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Watson JE; Kamkar S; James K; Kowbel D; Andaya A; Paris PL; Simko J; Carroll P; McAlhany S; Rowley D; Collins C Prostate; 2004 Oct; 61(2):192-9. PubMed ID: 15305342 [TBL] [Abstract][Full Text] [Related]
19. L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. Stoeck A; Schlich S; Issa Y; Gschwend V; Wenger T; Herr I; Marmé A; Bourbie S; Altevogt P; Gutwein P Cancer Lett; 2006 Aug; 239(2):212-26. PubMed ID: 16377081 [TBL] [Abstract][Full Text] [Related]
20. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis. Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]